1-[5-(Trifluoromethyl)pyrid-2-yl]-1,4-diazepane
95%
- Product Code: 242097
CAS:
306934-70-3
Molecular Weight: | 245.24 g./mol | Molecular Formula: | C₁₁H₁₄F₃N₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD00661783 | |
Melting Point: | 50 °C | Boiling Point: | 110 °C |
Density: | 1.212±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Commonly employed in medicinal chemistry for optimizing drug candidates due to its favorable pharmacokinetic properties and metabolic stability. Also utilized in the preparation of bioactive molecules for neurological and inflammatory disorders.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
1g | 10-20 days | ฿3,120.00 |
+
-
|
5g | 10-20 days | ฿11,760.00 |
+
-
|
25g | 10-20 days | ฿48,000.00 |
+
-
|
1-[5-(Trifluoromethyl)pyrid-2-yl]-1,4-diazepane
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Commonly employed in medicinal chemistry for optimizing drug candidates due to its favorable pharmacokinetic properties and metabolic stability. Also utilized in the preparation of bioactive molecules for neurological and inflammatory disorders.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :